Photochemotherapy
Photochemotherapy is treatment in which a light-absorbing drug is given first and then activated by light of a matched wavelength, so that the drug is inert until illumination and the effect is confined to the tissue exposed.
Photochemotherapy is treatment in which a light-absorbing drug is given first and then activated by light of a matched wavelength, so that the drug is inert until illumination and the effect is confined to the tissue exposed. Two distinct modalities share that description. In the classical sense the term denotes psoralen plus ultraviolet A (PUVA): psoralens intercalate into DNA and, on UVA exposure, form covalent adducts and interstrand crosslinks that suppress the proliferating and immune cells of the skin. This route needs no oxygen. In photodynamic therapy (PDT) the mechanism is different — a photosensitizer absorbs a photon and transfers the energy to molecular oxygen, generating singlet oxygen and other reactive oxygen species that damage membranes, organelles such as the mitochondrion and DNA, killing cells by apoptosis or necrosis. Because PDT consumes oxygen to work, hypoxic tissue resists it, a limitation PUVA does not share.
Both confer spatiotemporal control: cytotoxicity occurs only where drug and light coincide, which spares untreated tissue and largely avoids the systemic toxicity of chemotherapy or radiotherapy. The trade-off is reach — light penetrates a few millimetres of tissue, so accessible surfaces and cavities are treatable while deep or disseminated disease is not, and patients remain photosensitive until the drug clears.
PUVA is used for psoriasis, vitiligo, mycosis fungoides and other cutaneous T-cell lymphomas, and in extracorporeal photopheresis for graft-versus-host disease, where blood is treated outside the body and returned; long-term use raises skin cancer risk, which has narrowed its role since targeted immunomodulators appeared. PDT is established in oncology and dermatology for malignant disease of the skin, bladder cancer, and head and neck tumors, while applications in ovarian cancer, liver cancer, breast, colorectal and prostate tumors are predominantly investigational, and pre-cancerous lesions including those driven by high-risk human papillomavirus. It is also used against infection, eradicating bacteria in wounds and biofilms, where killing by short-lived oxidants rather than by a molecular target makes resistance difficult to acquire.
Where the papers sit
12 papers from the last 6 months study photochemotherapy directly · updated from PubMed 4 Oct 2026
Study type 0 clinical trials · 1 observational · 1 human data · 10 preclinical
Themes no clear themes · 1 new direction
Those 12 do not share a common subject.
-
Light-activated treatment is applied across antimicrobial dentistry, extramammary Paget's disease, oral and lung cancers, skin tumors, retinoblastoma, and broader oncology. Nanoparticles, exosomes, microneedles, imaging guidance, and metabolic or immune modulation recur as enabling strategies. The reported endpoints range from treatment response and targeting to imaging and antimicrobial activity. This mixture supports no common therapeutic direction or shared clinical question.
Photodynamic therapy becomes a switch for immunogenic extracellular-vesicle production rather than merely a tumor-killing treatment
The EVOTAC nanoproteolysis-targeting chimera for tumor-derived extracellular vesicles uses photodynamic therapy to reactivate vesicle production after initially suppressing it, causing tumor cells to release predominantly immunogenic vesicles that inhibit tumor growth, migration, and metastasis while increasing mature dendritic cells. Whereas the other studies use photochemotherapy to kill diseased cells, enhance drug delivery, or guide treatment, this work assigns it a new regulatory role: PDT helps reprogram the tumor secretome and thereby redirect intercellular signaling toward antitumor immunity 42420241Jul.
Papers
The 12 papers from the last 6 months that study photochemotherapy directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
No clear themes (12)
- Resveratrol-loaded human dental pulp stem cell-derived exosomes enhance the efficacy of blue LED-mediated antimicrobial photodynamic therapy against mature cariogenic biofilms. Lasers in medical science · 11 Sept 2026 PMID 42726144
- Treatment outcomes and influencing factors of photodynamic therapy in extramammary Paget's disease: a retrospective analysis of 31 cases. The Journal of dermatological treatment · 3 Aug 2026 PMID 42545809
- Development of novel nanoliposomes co-loaded with ROR1 inhibitor and Ce6 for the treatment of EGFR-TKIs resistant NSCLC by synergistic targeted inhibitor therapy and photodynamic therapy. Journal of photochemistry and photobiology. B, Biology · 31 Jul 2026 PMID 42537451
- Development of dual-function optical microneedle lens array for skin cancer treatment by photodynamic therapy. Lab on a chip · 29 Jul 2026 PMID 42522590
- Biomineralization-Derived Gadolinium Nanoparticles for Dual-Modal 1H/19F MRI-Guided Photodynamic Tumor Therapy. ACS applied materials & interfaces · 13 Jul 2026 PMID 42439866
- Construction of a Glutathione-Gated Intelligent Nanoclassifier for Spatioselective Visualization of Dual CircRNAs and Synergistic Photodynamic Therapy. Angewandte Chemie (International ed. in English) · 10 Jul 2026 PMID 42429128
- Switching tumor-derived extracellular vesicles off and on via targeted proteolysis to shift toward immunogenic phenotypes. Signal transduction and targeted therapy · 8 Jul 2026 PMID 42420241
- Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy. Journal of controlled release : official journal of the Controlled Release Society · 3 Jul 2026 PMID 42398835
- Metformin enhances methylene blue-mediated photodynamic therapy in oral squamous cell carcinoma. Journal of the Egyptian National Cancer Institute · 21 Jun 2026 PMID 42324424
- Ethanol-responsive fluorene-based fluorescent nanoprobes for photodynamic cancer therapy. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300645
- Near-infrared light-triggered, self-amplifying targeted drug-delivery platform achieves precision treatment of retinoblastoma. International journal of pharmaceutics · 10 Jun 2026 PMID 42269794
- Titanium dioxide nanoparticles in oncology: synthesis, application, and challenges. Cell biology and toxicology · 17 Apr 2026 PMID 41998363
By study type
Observational studies and case reports (1)
- Treatment outcomes and influencing factors of photodynamic therapy in extramammary Paget's disease: a retrospective analysis of 31 cases. The Journal of dermatological treatment · 3 Aug 2026 PMID 42545809
Human data, design not indexed (1)
- Resveratrol-loaded human dental pulp stem cell-derived exosomes enhance the efficacy of blue LED-mediated antimicrobial photodynamic therapy against mature cariogenic biofilms. Lasers in medical science · 11 Sept 2026 PMID 42726144
Preclinical: animal, cell and lab studies (10)
- Development of novel nanoliposomes co-loaded with ROR1 inhibitor and Ce6 for the treatment of EGFR-TKIs resistant NSCLC by synergistic targeted inhibitor therapy and photodynamic therapy. Journal of photochemistry and photobiology. B, Biology · 31 Jul 2026 PMID 42537451
- Development of dual-function optical microneedle lens array for skin cancer treatment by photodynamic therapy. Lab on a chip · 29 Jul 2026 PMID 42522590
- Biomineralization-Derived Gadolinium Nanoparticles for Dual-Modal 1H/19F MRI-Guided Photodynamic Tumor Therapy. ACS applied materials & interfaces · 13 Jul 2026 PMID 42439866
- Construction of a Glutathione-Gated Intelligent Nanoclassifier for Spatioselective Visualization of Dual CircRNAs and Synergistic Photodynamic Therapy. Angewandte Chemie (International ed. in English) · 10 Jul 2026 PMID 42429128
- Switching tumor-derived extracellular vesicles off and on via targeted proteolysis to shift toward immunogenic phenotypes. Signal transduction and targeted therapy · 8 Jul 2026 PMID 42420241
- Metabolic regulation-driven nanoparticles for tumor vulnerabilization and enhanced photodynamic therapy. Journal of controlled release : official journal of the Controlled Release Society · 3 Jul 2026 PMID 42398835
- Metformin enhances methylene blue-mediated photodynamic therapy in oral squamous cell carcinoma. Journal of the Egyptian National Cancer Institute · 21 Jun 2026 PMID 42324424
- Ethanol-responsive fluorene-based fluorescent nanoprobes for photodynamic cancer therapy. Journal of materials chemistry. B · 16 Jun 2026 PMID 42300645
- Near-infrared light-triggered, self-amplifying targeted drug-delivery platform achieves precision treatment of retinoblastoma. International journal of pharmaceutics · 10 Jun 2026 PMID 42269794
- Titanium dioxide nanoparticles in oncology: synthesis, application, and challenges. Cell biology and toxicology · 17 Apr 2026 PMID 41998363
Written from 12 PubMed abstracts, each one listed by PMID above. Published: 2026-06-15. Last written: 2026-09-13 by GPT. Corrections: 2026-09-26 by GPT. Drafted by language models from published abstracts; not medical advice.